SCHEMBL104888

SCHEMBL104888

CC(C)=NCc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS2 P35228 3/20 0.65
▸ GRIN2B Q13224 10/20 0.54
▸ GRIN1 Q05586 6/20 0.54
▸ GRIN2D O15399 2/20 0.48
▸ GRIN3B O60391 2/20 0.48
▸ GRIN2A Q12879 2/20 0.48
▸ GRIN2C Q14957 2/20 0.48
▸ GRIN3A Q8TCU5 2/20 0.48
▸ SIGMAR1 Q99720 2/20 0.48
▸ ALDH1A1 P00352 4/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ TRPA1 O75762 1/20 0.43
▸ MIF P14174 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ NOS3 P29474 2/20 0.42
▸ NOS1 P29475 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13308789 0.87 NOS2 (0.50) NOS2GRIN2BGRIN1GRIN2DGRIN3B
SCHEMBL22068858 0.85 NOS2 (0.65) NOS2GRIN2BGRIN1GRIN2DGRIN3B
SCHEMBL22068857 0.85 NOS2 (0.65) NOS2GRIN2BGRIN1GRIN2DGRIN3B
SCHEMBL20675953 0.81 NOS2 (0.96) NOS2GRIN2BGRIN1GRIN2DGRIN3B
SCHEMBL14291059 0.81 NOS2 (0.96) NOS2GRIN2BGRIN1GRIN2DGRIN3B
SCHEMBL6191953 0.81 NOS2 (0.61) NOS2GRIN2BGRIN1GRIN2DGRIN3B
Bromide SCHEMBL3600819 0.79 NOS2 (0.64) NOS2GRIN2BGRIN1GRIN2DGRIN3B
Hydrochloric Acid SCHEMBL4737504 0.79 NOS2 (0.92) NOS2GRIN2BGRIN1GRIN2DGRIN3B
SCHEMBL987917 0.79 GRIN2B (0.59) NOS2GRIN2BGRIN1GRIN2DGRIN3B
SCHEMBL164345 0.79 GRIN2B (0.59) NOS2GRIN2BGRIN1GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110372595-A A kind of Actinochemical synthesis of imidazoles alkyl compound 北京工商大学 2019-10-25 — — CN claimed
US-6271387-B1 Process for producing 1,3-oxazolidine derivatives DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2001-08-07 — — US claimed
US-20250333548-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO LTD (JP) 2025-10-30 — — US disclosed
US-20250282900-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2025-09-11 — — US disclosed
US-20250138421-A1 PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2025-05-01 — — US disclosed
US-20250060668-A1 PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2025-02-20 — — US disclosed
US-20240402602-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-12-05 — — US disclosed
US-20240384056-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-11-21 — — US disclosed
US-20240239922-A1 PHOTOCURABLE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-07-18 — — US disclosed
US-20240192593-A1 PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-06-13 — — US disclosed
US-20240191003-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-06-13 — — US disclosed
US-20020151571-A1 Cyclic imines as pesticides PLANT ANDREW (DE) 2002-10-17 — — US disclosed
US-6399771-B1 AGRICULTURE; VETERINARY MEDICINE BAYER AKTIENGESELLSCHAFT (DE) 2002-06-04 — — US disclosed
EP-1178031-A1 PROCESS FOR THE PREPARATION OF ORGANIC COMPOUNDS WITH MANGANESE CATALYSTS OR THE LIKE Daicel Chemical Industries, Ltd. (JP) 2002-02-06 — — EP disclosed
US-6323346-B1 REACTING A DIAZOACETIC ACID DERIVATIVE OF THE FORMULA N.SUB.2 CHR.SUP.4 WITH A CARBONYL COMPOUND OF FORMULA R.SUP.1 R.SUP.2 C.DBD.O AND AN AMINO-GROUP-CONTAINING COMPOUND OF FORMULA R.SUP.3 NH.SUB.2 IN THE PRESENCE OF AN IRIDIUM COMPLEX DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2001-11-27 — — US disclosed
US-6274613-B1 APPLYING COMPOUNDS SUCH AS A GAMMA-ETHOXY-GAMMA-BUTYROLACTAM TO PESTS AND/OR THEIR HABITATS BAYER AKTIENGESELLSCHAFT (DE) 2001-08-14 — — US disclosed
US-6271387-B1 Process for producing 1,3-oxazolidine derivatives DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2001-08-07 — — US disclosed
EP-1038866-A1 Process for producing aziridine compound Daicel Chemical Industries, Ltd. (JP) 2000-09-27 — — EP disclosed
EP-1026161-A1 Process for producing 1,3-oxazolidine derivatives Daicel Chemical Industries, Ltd. (JP) 2000-08-09 — — EP disclosed
EP-0084783-A1 Process for preparing N-isopropylidene amines BAYER AG (DE) 1983-08-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240402602-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION CHMP4B, PHOSPHO1, EXOSC9 NOS2 833/4885GRIN2B 1001/4885GRIN1 2499/4885
US-20020151571-A1 Cyclic imines as pesticides DDT, CYP1A1, AR NOS2 3388/4885GRIN2B 487/4885GRIN1 21/4885
US-20240384056-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION CHMP4B, PHOSPHO1, EXOSC9 NOS2 865/4885GRIN2B 995/4885GRIN1 2500/4885
US-20240192593-A1 PHOTOSENSITIVE COMPOSITION PPOX, ERCC1, ERCC5 NOS2 808/4885GRIN2B 1496/4885GRIN1 2319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback